These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18612136)

  • 1. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.
    Gail MH
    J Natl Cancer Inst; 2008 Jul; 100(14):1037-41. PubMed ID: 18612136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model.
    Gail MH
    J Natl Cancer Inst; 2009 Jul; 101(13):959-63. PubMed ID: 19535781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
    Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
    J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model.
    Dite GS; Mahmoodi M; Bickerstaffe A; Hammet F; Macinnis RJ; Tsimiklis H; Dowty JG; Apicella C; Phillips KA; Giles GG; Southey MC; Hopper JL
    Breast Cancer Res Treat; 2013 Jun; 139(3):887-96. PubMed ID: 23774992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.
    Spitz MR; Amos CI; D'Amelio A; Dong Q; Etzel C
    J Natl Cancer Inst; 2009 Dec; 101(24):1731-2; author reply 1732. PubMed ID: 19903803
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women.
    Dai J; Hu Z; Jiang Y; Shen H; Dong J; Ma H; Shen H
    Breast Cancer Res; 2012 Jan; 14(1):R17. PubMed ID: 22269215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
    Mealiffe ME; Stokowski RP; Rhees BK; Prentice RL; Pettinger M; Hinds DA
    J Natl Cancer Inst; 2010 Nov; 102(21):1618-27. PubMed ID: 20956782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.
    Banegas MP; John EM; Slattery ML; Gomez SL; Yu M; LaCroix AZ; Pee D; Chlebowski RT; Hines LM; Thompson CA; Gail MH
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 28003316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement.
    Darabi H; Czene K; Zhao W; Liu J; Hall P; Humphreys K
    Breast Cancer Res; 2012 Feb; 14(1):R25. PubMed ID: 22314178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a genetic risk score for Arkansas women of color.
    Starlard-Davenport A; Allman R; Dite GS; Hopper JL; Spaeth Tuff E; Macleod S; Kadlubar S; Preston M; Henry-Tillman R
    PLoS One; 2018; 13(10):e0204834. PubMed ID: 30281645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
    Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
    J Genet; 2020; 99():. PubMed ID: 32366738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study.
    Milne RL; Gaudet MM; Spurdle AB; Fasching PA; Couch FJ; Benítez J; Arias Pérez JI; Zamora MP; Malats N; Dos Santos Silva I; Gibson LJ; Fletcher O; Johnson N; Anton-Culver H; Ziogas A; Figueroa J; Brinton L; Sherman ME; Lissowska J; Hopper JL; Dite GS; Apicella C; Southey MC; Sigurdson AJ; Linet MS; Schonfeld SJ; Freedman DM; Mannermaa A; Kosma VM; Kataja V; Auvinen P; Andrulis IL; Glendon G; Knight JA; Weerasooriya N; Cox A; Reed MW; Cross SS; Dunning AM; Ahmed S; Shah M; Brauch H; Ko YD; Brüning T; ; Lambrechts D; Reumers J; Smeets A; Wang-Gohrke S; Hall P; Czene K; Liu J; Irwanto AK; Chenevix-Trench G; Holland H; ; ; Giles GG; Baglietto L; Severi G; Bojensen SE; Nordestgaard BG; Flyger H; John EM; West DW; Whittemore AS; Vachon C; Olson JE; Fredericksen Z; Kosel M; Hein R; Vrieling A; Flesch-Janys D; Heinz J; Beckmann MW; Heusinger K; Ekici AB; Haeberle L; Humphreys MK; Morrison J; Easton DF; Pharoah PD; García-Closas M; Goode EL; Chang-Claude J
    Breast Cancer Res; 2010; 12(6):R110. PubMed ID: 21194473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of breast cancer risk genes and establishment of a prediction model based on estrogen metabolism regulation.
    Zhao F; Hao Z; Zhong Y; Xu Y; Guo M; Zhang B; Yin X; Li Y; Zhou X
    BMC Cancer; 2021 Feb; 21(1):194. PubMed ID: 33632172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.
    Rinella ES; Shao Y; Yackowski L; Pramanik S; Oratz R; Schnabel F; Guha S; LeDuc C; Campbell CL; Klugman SD; Terry MB; Senie RT; Andrulis IL; Daly M; John EM; Roses D; Chung WK; Ostrer H
    Hum Genet; 2013 May; 132(5):523-36. PubMed ID: 23354978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
    Antoniou AC; Beesley J; McGuffog L; Sinilnikova OM; Healey S; Neuhausen SL; Ding YC; Rebbeck TR; Weitzel JN; Lynch HT; Isaacs C; Ganz PA; Tomlinson G; Olopade OI; Couch FJ; Wang X; Lindor NM; Pankratz VS; Radice P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Viel A; Allavena A; Dall'Olio V; Peterlongo P; Szabo CI; Zikan M; Claes K; Poppe B; Foretova L; Mai PL; Greene MH; Rennert G; Lejbkowicz F; Glendon G; Ozcelik H; Andrulis IL; ; Thomassen M; Gerdes AM; Sunde L; Cruger D; Birk Jensen U; Caligo M; Friedman E; Kaufman B; Laitman Y; Milgrom R; Dubrovsky M; Cohen S; Borg A; Jernström H; Lindblom A; Rantala J; Stenmark-Askmalm M; Melin B; ; Nathanson K; Domchek S; Jakubowska A; Lubinski J; Huzarski T; Osorio A; Lasa A; Durán M; Tejada MI; Godino J; Benitez J; Hamann U; Kriege M; Hoogerbrugge N; van der Luijt RB; van Asperen CJ; Devilee P; Meijers-Heijboer EJ; Blok MJ; Aalfs CM; Hogervorst F; Rookus M; ; Cook M; Oliver C; Frost D; Conroy D; Evans DG; Lalloo F; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Hodgson S; Morrison PJ; Porteous ME; Walker L; Kennedy MJ; Dorkins H; Peock S; ; Godwin AK; Stoppa-Lyonnet D; de Pauw A; Mazoyer S; Bonadona V; Lasset C; Dreyfus H; Leroux D; Hardouin A; Berthet P; Faivre L; ; Loustalot C; Noguchi T; Sobol H; Rouleau E; Nogues C; Frénay M; Vénat-Bouvet L; ; Hopper JL; Daly MB; Terry MB; John EM; Buys SS; Yassin Y; Miron A; Goldgar D; ; Singer CF; Dressler AC; Gschwantler-Kaulich D; Pfeiler G; Hansen TV; Jønson L; Agnarsson BA; Kirchhoff T; Offit K; Devlin V; Dutra-Clarke A; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov E; Tihomirova L; Blanco I; Lazaro C; Ramus SJ; Sucheston L; Karlan BY; Gross J; Schmutzler R; Wappenschmidt B; Engel C; Meindl A; Lochmann M; Arnold N; Heidemann S; Varon-Mateeva R; Niederacher D; Sutter C; Deissler H; Gadzicki D; Preisler-Adams S; Kast K; Schönbuchner I; Caldes T; de la Hoya M; Aittomäki K; Nevanlinna H; Simard J; Spurdle AB; Holland H; Chen X; ; Platte R; Chenevix-Trench G; Easton DF;
    Cancer Res; 2010 Dec; 70(23):9742-54. PubMed ID: 21118973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers.
    Park JH; Gail MH; Greene MH; Chatterjee N
    J Clin Oncol; 2012 Jun; 30(17):2157-62. PubMed ID: 22585702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive accuracy of the breast cancer genetic risk model based on eight common genetic variants: The BACkSIDE study.
    Danková Z; Žúbor P; Grendár M; Zelinová K; Jagelková M; Stastny I; Kapinová A; Vargová D; Kasajová P; Dvorská D; Kalman M; Danko J; Lasabová Z
    J Biotechnol; 2019 Jun; 299():1-7. PubMed ID: 31002855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating breast cancer risk projections for Hispanic women.
    Banegas MP; Gail MH; LaCroix A; Thompson B; Martinez ME; Wactawski-Wende J; John EM; Hubbell FA; Yasmeen S; Katki HA
    Breast Cancer Res Treat; 2012 Feb; 132(1):347-53. PubMed ID: 22147080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer.
    Tapper W; Hammond V; Gerty S; Ennis S; Simmonds P; Collins A; ; Eccles D
    Breast Cancer Res; 2008; 10(6):R108. PubMed ID: 19094228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population.
    Sueta A; Ito H; Kawase T; Hirose K; Hosono S; Yatabe Y; Tajima K; Tanaka H; Iwata H; Iwase H; Matsuo K
    Breast Cancer Res Treat; 2012 Apr; 132(2):711-21. PubMed ID: 22160591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.